Elevated High Sensitivity Cardiac Troponin T is Nonlinearly Associated with Poor Prognosis in Aging COVID-19

Xiaxia Jin1, Haideng Yang2, Weiwei Ma1

  • 1Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.

PubMed

Insights

High-sensitivity cardiac troponin T (hs-cTnT) levels predict death and major adverse events in elderly COVID-19 patients. The risk increases non-linearly with hs-cTnT, highlighting its prognostic value.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Geriatrics

Background:

  • Coronavirus disease 2019 (COVID-19) poses significant risks to elderly populations.
  • Cardiac biomarkers, such as high-sensitivity cardiac troponin T (hs-cTnT), are crucial for assessing cardiac injury and prognosis.

Purpose of the Study:

  • To evaluate the prognostic value of hs-cTnT in elderly patients diagnosed with COVID-19.
  • To determine the relationship between hs-cTnT levels and in-hospital mortality and major adverse events.

Main Methods:

  • A cohort of 1399 elderly COVID-19 patients (≥65 years) was analyzed.
  • Cox and logistic regression models assessed the association between hs-cTnT and outcomes.
  • Restricted cubic spline (RCS) models were employed for nonlinear association analysis.

Main Results:

  • Elevated peak hs-cTnT levels significantly correlated with increased risk of death (HR 9.49) and major adverse events (OR 20.59).
  • Nonlinear analysis revealed a steep, S-shaped increase in risk from 3 ng/L hs-cTnT, plateauing around 131 ng/L.
  • Peak hs-cTnT demonstrated strong predictive value for in-hospital death (AUC 0.834) and major adverse events (AUC 0.804).

Conclusions:

  • Peak hs-cTnT is a potent predictor of in-hospital mortality and major adverse events in elderly COVID-19 patients.
  • The association between peak hs-cTnT and adverse outcomes is nonlinear, with risk escalating significantly at lower levels.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9